A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia
Titel:
A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia
Auteur:
Archimbaud, Eric Ottmann, Oliver G. Yin, John A. Liu Lechner, Klaus Dombret, Herve Sanz, Miguel A. Heil, Gerhard Fenaux, Pierre Brugger, Wolfram Barge, Alan O'Brien-Ewen, Caroline Matcham, James Hoelzer, Dieter